FindTrial
Sign In

No Biologics

DEVICE3 trials

Sponsors

Janssen Biotech, Inc., Ningbo No. 1 Hospital, Assiut University

Conditions

Breast CancerCrohn's DiseaseIdentification of Influencing Factors and Construction of a Prediction Model for New-Onset Diabetes After PancreatectomyIndeterminate ColitisInflammatory Bowel DiseasesUlcerative Colitis

Unknown Phase

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Active, not recruitingNCT00606346
Janssen Biotech, Inc.Crohn's Disease, Indeterminate Colitis, Inflammatory Bowel Diseases +1
Start: 2007-05-31End: 2038-06-30Updated: 2026-08-28
Development and Validation of a Risk Prediction Model for New-Onset Diabetes After Pancreatectomy
CompletedNCT07436273
Ningbo No. 1 HospitalIdentification of Influencing Factors and Construction of a Prediction Model for New-Onset Diabetes After Pancreatectomy
Start: 2023-06-01End: 2025-06-30Updated: 2026-02-27
Role of PCGEM1 in Breast Cancer
Not yet recruitingNCT07562789
Assiut UniversityBreast Cancer
Start: 2026-05-05End: 2026-08-06Target: 90Updated: 2026-05-01

Related Papers

Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
2017-02-11146 citations